The landscape of dementia prognosis has developed significantly with the appearance of subtle biomarkers, which include amyloid PET scans, tau imaging, and blood-based mostly tests that will detect Alzheimer's pathology many years before signs or symptoms emerge. Though these technological improvements signify extraordinary progress in being familiar with neurodegenerative conditions, https://ferdinandt875zly9.plpwiki.com/user